je.st
news
GlaxoSmithKline opts to hold on to HIV business
2015-05-06 15:04:10| Biotech - Topix.net
British-based drugmaker GlaxoSmithKline has opted to keep its stand-alone HIV business as it set out its strategy following the completion of its recent deal with Switzerland's Novartis. GSK said it has cancelled an initial public offering of its HIV business, ViiV Healthcare, opting instead to retain its full holding in the joint venture with equity partners Pfizer and Shiongi.
Tags: business
hold
hiv
glaxosmithkline
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||